ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W107. A total of 40 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $342,000 | +182.6% | 972,285 | +56.4% | 0.07% | +38.0% |
| Q1 2020 | $121,000 | -83.0% | 621,840 | -81.0% | 0.05% | -74.7% |
| Q4 2019 | $713,000 | -64.8% | 3,275,718 | -62.8% | 0.20% | -81.8% |
| Q3 2019 | $2,023,000 | -1.5% | 8,797,509 | +5.4% | 1.09% | -57.8% |
| Q2 2019 | $2,053,000 | +40.8% | 8,343,716 | +108.8% | 2.58% | +2866.7% |
| Q1 2018 | $1,458,000 | +4.1% | 3,995,400 | +64.1% | 0.09% | -4.4% |
| Q3 2017 | $1,400,000 | +84.2% | 2,434,103 | +180.2% | 0.09% | +106.8% |
| Q4 2016 | $760,000 | -59.3% | 868,608 | -37.2% | 0.04% | -37.1% |
| Q3 2016 | $1,867,000 | +1443.0% | 1,382,629 | +1920.6% | 0.07% | +1300.0% |
| Q3 2015 | $121,000 | – | 68,427 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 90,000 | $222,000 | 0.17% |
| EQUITEC SPECIALISTS, LLC | 21,820 | $54,000 | 0.02% |
| TFS CAPITAL LLC | 46,886 | $116,000 | 0.01% |
| Westend Capital Management, LLC | 1,000 | $3,000 | 0.00% |
| A.R.T. Advisors, LLC | 33,414 | $82,000 | 0.00% |
| Virtu KCG Holdings LLC | 31,765 | $78,000 | 0.00% |
| RHUMBLINE ADVISERS | 14,080 | $35,000 | 0.00% |
| BNP PARIBAS FINANCIAL MARKETS | 1,115 | $2,754,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 151,489 | $374,000 | 0.00% |
| BlackRock Investment Management, LLC | 73,717 | $182,000 | 0.00% |